KorMedi
  • Beauty
  • Health
  • Lifestyle
  • Medicine
  • Biowatch
  • Column
  • Kormedi.com TV
  • Notice
KorMedi
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice

Search results for "Hanmi Pharmaceutical"

Home
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals

Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals

The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened Tuesday at Phoenix Island in Jeju.
07/06/2026, 03:43 ET
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?

HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?

HK inno. N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s Sciwind Biosciences.
03/23/2026, 02:59 ET
Previous12
KorMedi
  • Business registration number: 214-87-97051
  • Press registration number: Seoul A 00292
  • Registration date: 2006-11-30
  • Title: Kormedi.com
  • Representative number: 02-2052-8200
  • Address: 41, Mapo-daero 4da-gil, Mapo-gu, Seoul, Henkel Tower (2nd Floor, Mapo Tower)
  • Issue date: November 30, 2006
  • Publisher and Editor-in-Chief: Seong Ju Lee
  • Youth Protection Officer: Simon Hong
  • Company Introduction
  • Privacy Policy
  • Terms of Service
  • Youth Protection Policy
  • Email Collection Refusal
  • Advisory Board
  • Advertising and Partnership Inquiries

Kormedi.com does not provide medical advice, diagnosis or treatment.

Multilingual content on this site is generated using AI-based translation and may contain errors or differences in interpretation. For legal or medical matters, please refer to the original language version.

© 2026 KoreaMedicare. All Rights Reserved.Powered by 팡고링고
Languages

ENGLISH

English (US)

ASIAN

日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية